Bausch Health Companies | VRX - Sales Revenues



Bausch Health Companies reported $2.53B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Amgen USD 9.18B 1.03B Jun/2025
ANI Pharmaceuticals USD 211.37M 14.27M Jun/2025
Aurora Cannabis CAD 98.02M 9.82M Jun/2025
Bausch Health Companies USD 2.53B 270M Jun/2025
Biogen USD 2.6B 170M Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
Canopy Growth CAD 72.13M 2.63M Jun/2025
Corcept Therapeutics USD 194.4M 37.2M Jun/2025
Danaher USD 5.94B 200M Jun/2025
Drreddys Laboratories INR 85.45B 1.87B Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
Gilead Sciences USD 7.1B 430M Jun/2025
Novo Nordisk 76.86B 1.23B Jun/2025
Pacira USD 181.1M 12.18M Jun/2025
Perrigo USD 1.06B 20M Jun/2025
Prestige Brands USD 249.53M 46.99M Jun/2025
Supernus Pharmaceuticals USD 165.5M 15.7M Jun/2025
Vertex Pharmaceuticals USD 2.96B 190M Jun/2025
Zoetis USD 2.46B 240M Jun/2025